InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: JRIII post# 188105

Saturday, 09/01/2018 3:16:48 PM

Saturday, September 01, 2018 3:16:48 PM

Post# of 700778
American Brain Tumor Association
18 jun. 2018

In this webinar, Dr. Michael Lim MD, Professor of Neurosurgery, Oncology, Otolaryngology, and Radiation Oncology at Johns Hopkins takes a comprehensive look into immunotherapy as a treatment option for brain tumors. Immunotherapy has gained a great deal of attention for many different tumors. Dr. Lim will discuss the state of the field for immunotherapy for GBM and future directions.

Dr. Michael Lim MD, and DCVAX-L trial:
Min.20.09
Quote:
“This is very early on but again very interesting results”
Quote:
“We think that it’s still a very interesting and promising approach”



NOTE:

Upcoming Webinars
September 13 @ 1:00 pm CST

Novel Designs for Brain Tumor Clinical Trials presented by Celgene
Dr. Timothy Cloughesy, MD, UCLA Health

https://www.abta.org/about-brain-tumors/brain-tumor-faqs/webinars/
Register now: https://register.gotowebinar.com/register/2437385674464009730
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News